Fate Therapeutics, Inc. (FATE)
USD 1.69
(-10.37%)
USD 1.69
(-10.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -132.26 Million | -248.2 Million | -162.87 Million | -39.22 Million | -83.17 Million | -38.65 Million |
| Net Income | -160.92 Million | -281.72 Million | -212.15 Million | -173.38 Million | -98.14 Million | -66.59 Million |
| Depreciation & Amortization | 18.28 Million | 13.75 Million | 5.85 Million | 3.08 Million | 2.19 Million | 1.2 Million |
| Deferred income taxes | -7.71 Million | - | 5.06 Million | 1.67 Million | -478 Thousand | -335 Thousand |
| Stock-based compensation | 43.45 Million | 78.73 Million | 54.36 Million | 30.75 Million | 17.41 Million | 6.29 Million |
| Change in working capital | 19.18 Million | -34.71 Million | 2.09 Million | -12.77 Million | 3.64 Million | 1.74 Million |
| Other non-cash items | -44.54 Million | -24.26 Million | -18.09 Million | 111.41 Million | -7.79 Million | 19.04 Million |
| Investing Cash Flow | 112.66 Million | 166.75 Million | -324.02 Million | -161.07 Million | -157.45 Million | -463 Thousand |
| Investments in PPE | -6.15 Million | -35.56 Million | -50.7 Million | -4.93 Million | -7.39 Million | -2.3 Million |
| Acquisitions | -118.81 Million | -202.31 Million | 273.31 Million | 156.14 Million | 150.05 Million | - |
| Investment purchases | -358.81 Million | -404.79 Million | -968.15 Million | -277.34 Million | -248.85 Million | -55.66 Million |
| Sales/Maturities of investments | 477.62 Million | 607.11 Million | 694.84 Million | 121.2 Million | 98.8 Million | 57.5 Million |
| Other Investing Activities | 118.81 Million | 202.31 Million | -273.31 Million | -156.14 Million | -150.05 Million | 1.84 Million |
| Financing Cash Flow | 85 Thousand | 9.2 Million | 453.12 Million | 282.83 Million | 149.92 Million | 140.78 Million |
| Debt repayment | - | - | - | - | -15 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | 2.52 Million | 2.69 Million |
| Common Stock Issuance | 85 Thousand | 9.2 Million | 453.12 Million | 282.34 Million | 162.4 Million | 137.27 Million |
| Other Financing Activities | 85 Thousand | 9.2 Million | 453.12 Million | 282.83 Million | 149.92 Million | 140.78 Million |
| Accounts receivables | 36.65 Million | -29.8 Million | -3.16 Million | -5.51 Million | 500 Thousand | -500 Thousand |
| Accounts payables | -28.94 Million | 14.25 Million | 5.9 Million | -1.55 Million | 4.27 Million | 4.25 Million |
| Inventory | - | - | -5.9 Million | 1.55 Million | -4.27 Million | -4.25 Million |
| Other working capital | 11.46 Million | -19.15 Million | 5.25 Million | -7.25 Million | 3.14 Million | 2.24 Million |
| Cash at beginning of period | 61.33 Million | 148.81 Million | 182.57 Million | 100.04 Million | 190.74 Million | 89.07 Million |
| Cash at end of period | 41.87 Million | 76.56 Million | 148.81 Million | 182.57 Million | 100.04 Million | 190.74 Million |
| Capital Expenditure | -6.15 Million | -35.56 Million | -50.7 Million | -4.93 Million | -7.39 Million | -2.3 Million |
| Effect of forex changes on cash | 50 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -19.46 Million | -72.25 Million | -33.76 Million | 82.53 Million | -90.7 Million | 101.66 Million |
| Free Cash Flow | -138.41 Million | -283.77 Million | -213.57 Million | -44.16 Million | -90.57 Million | -40.95 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -38.42 Million | -48 Million | -160.92 Million | -44.12 Million | -45.17 Million | -52.75 Million |
| Depreciation & Amortization | 4.72 Million | 4.82 Million | 18.28 Million | 4.88 Million | 4.74 Million | 4.46 Million |
| Deferred income taxes | - | - | -7.71 Million | 6.19 Million | -3.25 Million | -2.94 Million |
| Stock-based compensation | 9.63 Million | 10.98 Million | 43.45 Million | 9.47 Million | 10.1 Million | 12.89 Million |
| Change in working capital | -3.79 Million | 614 Thousand | 19.18 Million | -189 Thousand | -2.82 Million | 14.04 Million |
| Other non-cash items | 14.5 Million | 22.4 Million | -44.54 Million | -12.88 Million | -1.86 Million | -4.2 Million |
| Investing Cash Flow | -53.37 Million | 17.31 Million | 112.66 Million | 45.35 Million | 24.8 Million | 33.16 Million |
| Investments in PPE | -51 Thousand | -86 Thousand | -6.15 Million | -181 Thousand | -565 Thousand | -2.19 Million |
| Acquisitions | - | - | -118.81 Million | 73.28 Million | -25.37 Million | -35.36 Million |
| Investment purchases | -128.66 Million | -86.33 Million | -358.81 Million | -49.96 Million | -102.13 Million | -92.26 Million |
| Sales/Maturities of investments | 75.34 Million | 103.73 Million | 477.62 Million | 95.5 Million | 127.5 Million | 127.62 Million |
| Other Investing Activities | -53.32 Million | 17.4 Million | 118.81 Million | -73.28 Million | 25.37 Million | 35.36 Million |
| Financing Cash Flow | 1.27 Million | 95.48 Million | 85 Thousand | -180 Thousand | - | 58 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -666 Thousand | - | - | -180 Thousand | - | - |
| Common Stock Issuance | -666 Thousand | 95.48 Million | 85 Thousand | -180 Thousand | - | 58 Thousand |
| Other Financing Activities | 1.94 Million | 95.48 Million | 85 Thousand | - | - | 58 Thousand |
| Accounts receivables | -190 Thousand | 968 Thousand | 36.65 Million | -288 Thousand | 1.29 Million | 10.66 Million |
| Accounts payables | 320 Thousand | -4.5 Million | -28.94 Million | -1.89 Million | -2.28 Million | -4.37 Million |
| Inventory | - | - | - | -6.65 Million | 2.28 Million | 4.37 Million |
| Other working capital | -3.92 Million | 4.15 Million | 11.46 Million | 8.64 Million | -4.11 Million | 3.37 Million |
| Cash at beginning of period | 121.32 Million | 41.87 Million | 61.33 Million | 33.33 Million | 61.97 Million | 57.24 Million |
| Cash at end of period | 36.91 Million | 121.32 Million | 41.87 Million | 41.87 Million | 48.51 Million | 61.97 Million |
| Capital Expenditure | -51 Thousand | -86 Thousand | -6.15 Million | -181 Thousand | -565 Thousand | -2.19 Million |
| Effect of forex changes on cash | - | - | 50 Thousand | - | - | - |
| Net cash flow / Change in cash | -84.4 Million | 79.45 Million | -19.46 Million | 8.53 Million | -13.46 Million | 4.73 Million |
| Free Cash Flow | -32.35 Million | -33.43 Million | -138.41 Million | -36.81 Million | -38.83 Million | -30.69 Million |
RHIM
PNPL
MERG
WFRD
8066
MRNJ